Lyric Bio, Inc. is a next-generation biomanufacturing startup developing human-tissue-based production systems for donor-derived therapeutics. The company is dedicated to building next-generation manufacturing for donor-derived and protein-based therapeutics, with an initial focus on immunoglobulin production.